The Journal Drug Designing: Open Access aims to fill this important knowledge barrier for decades. Here the Journal tries to provide a platform for them to meet their existence with the commitment to the research society by publishing their latest research. The Journal has been dealing with the case reports, original research and review articles about the pharmaceutical intervention safety, side effects, and adverse effects as well as medication toxicity.

Drug Discovery Research focuses on the latest research in all related fields of drug targets, rational drug discovery, computer-aided drug design and the different types of drug design, development methods. Drug Design and Drug Discovery Hit to Lead and its treatment and many other interesting research topics in the field of Drug Design and Discovery. The journal also involves the inventive process of finding new medications based on the knowledge of a biological target.

Drug Discovery mainly focuses on new compounds and technologies in all aspects of human therapeutics as well as to improve the global management health care policy and regulatory issues. New drugs that have been developed and the insights and advances from the combined use of chemical and biological research. Focused rational approach, target-based design, drug synthesis, drug metabolism, structure-based drug design, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic, Quality by design, Design for reliability in drug development, Design for traditional Chinese medicine clinical trials, Bayesian sequential design for multi-regional design, Design and analysis for target clinical trials, Design and analysis for diagnostic procedures, Adaptive design for early clinical development, Design for biosimilar studies, Design for bioassay development and validation, Design for statistical genetics, Design for assessment of drug to drug interaction, Design for bridging studies, Design for stability analysis.

Manuscripts can be submitted through the Editorial Tracking System https://www.longdom.org/drug-designing/submit-manuscript.html or  as an e-mail attachment to the Editorial Office at drugdesign@longdom.org

Regards,

Sherry Peterson

Journal Manager

Journal of Drug Designing: Open Access

drugdesign@longdom.org

 WhatsApp: +1-947-333-4405